Related by context. All words. (Click for frequent words.) 82 q8h 77 8mg/kg 76 alfa 2a 75 mcg BID 74 #mg/m# [002] 74 #mg/m# [001] 73 Peg IFN 73 abacavir lamivudine 73 ribavirin RBV 73 mg/m2/day 73 saline placebo 72 IV bolus 72 Q2W 72 mg m² 72 4mg/kg 72 #mg q8h 72 lopinavir r 72 lopinavir r arm 72 PEG IFN 72 mg/m2 IV 72 mg qd 72 mg QD 72 zonisamide SR 71 μg dose 71 3mg/kg 71 mg TID 71 doxorubicin cyclophosphamide 71 intravenous bolus 71 #mg QD [002] 71 mcg kg 71 LEXIVA r 70 plus methotrexate 70 administered subcutaneously 70 #mg BID [001] 70 ritonavir boosted 70 #mg/day [002] 70 salmeterol fluticasone 70 Copegus ribavirin 70 achieved ACR# 70 cyclophosphamide methotrexate 70 budesonide pMDI 70 tenofovir emtricitabine 70 mitoxantrone plus 70 ritonavir boosted atazanavir 70 Peginterferon Alfa 2a 70 highly emetogenic 69 dasatinib Sprycel ® 69 Pegasys peginterferon alfa 2a 69 plus prednisone prednisolone 69 rFSH 69 mcg albinterferon alfa 2b 69 mcg dose 69 mg administered orally 69 pegylated interferon alfa 2a 69 TO AVOID PREGNANCY WHILE 69 PEGINTRON TM 69 mg BID 69 FEMALES SHOULD BE ADVISED 69 ACTEMRA TM 69 insulin glulisine 69 mg/m2 dose 69 dalteparin 69 CIMZIA TM 69 unfractionated heparin UFH 69 ug kg 69 #mg BID [003] 69 fluticasone salmeterol 69 interferon alfa 2b 69 Oral Fingolimod 69 mg kg dose 69 docetaxel Taxotere ® 69 interferon alfa 2a 68 FUSILEV enhances 68 ® lenalidomide 68 peginterferon alfa 2a Pegasys 68 clodronate 68 efavirenz EFV 68 3TC lamivudine 68 mcg QD 68 piperacillin tazobactam 68 Peginterferon 68 ribavirin USP 68 oxycodone CR 68 injected subcutaneously 68 carboplatin paclitaxel 68 AZT zidovudine Retrovir 68 docetaxel chemotherapy 68 plus dexamethasone 68 PRN FDA Approves 68 mg/m2 administered 68 Xeloda ® 68 receiving INTRON 68 R# #mg BID 68 5 FU leucovorin 68 placebo intravenously 68 alpha 2a 68 Pegylated Liposomal Doxorubicin 68 Acetate Rectal Suppositories 68 ascending doses 68 mg orally 68 adalimumab Humira 68 Flu Cy 68 oral rivaroxaban 68 dosing cohorts 67 TMC# r 67 flutamide 67 potent CYP#A# inhibitors 67 IIIa inhibitor 67 #mg #mg #mg [003] 67 PROCTOCORT R 67 microgram kg 67 fluticasone furoate 67 subcutaneous enoxaparin 67 nadroparin 67 neutropenia dehydration dyspnea 67 fluorouracil leucovorin 67 REYATAZ r arm 67 ergot derivatives 67 plus gemcitabine 67 5-FU/LV 67 severe neutropenia 67 PREZISTA ritonavir 67 dexamethasone Decadron 67 pegylated interferon alpha 67 VELCADE melphalan 67 non splenectomized 67 tipranavir r 67 nadolol 67 treatment naïve genotype 67 plus prednisone 67 gemcitabine cisplatin 67 ribavirin therapy 67 Hormone Refractory Prostate Cancer 67 LANTUS R 67 evaluating tivozanib 67 q#d 67 nab paclitaxel 67 adriamycin 67 Investigational Oral 67 valsartan amlodipine 67 dacarbazine 67 certolizumab 67 Aptivus ® 67 FOLFIRI 67 LPV r 67 plus COPEGUS 67 #mg QD [001] 67 relapsed refractory multiple myeloma 67 dosing cohort 67 lispro 67 relapsed MM 67 #/#mg 67 cytarabine daunorubicin 67 paclitaxel cisplatin 67 mCi kg 67 desvenlafaxine succinate 67 mg ustekinumab 67 peg interferon 67 SPRYCEL ® 67 PegIFN 67 PEGASYS ® 67 placebo PBO 67 Tipranavir 67 Nebulized 67 peginterferon alfa 2b 67 peginterferon alpha 2a 67 humanized interleukin 6 67 HBeAg positive patients 67 R adefovir dipivoxil 67 continuous intravenous infusion 67 nevirapine Viramune 67 3TC lamivudine Epivir 67 stage IIIb IV 67 HCV RESPOND 2 67 MULTAQ 67 Hycamtin ® 67 mg simvastatin 66 alfa 2b 66 weekly subcutaneous injections 66 emtricitabine tenofovir 66 infliximab monotherapy 66 Randomized Phase 66 #.#g/day 66 pyrazinamide 66 candesartan cilexetil 66 mcg doses 66 achieved CCyR 66 recurrent glioblastoma multiforme 66 mitomycin 66 irinotecan doxorubicin oxaliplatin paclitaxel 66 administered intramuscularly 66 #mg dose [003] 66 mg/m2 66 mg subcutaneous 66 BENICAR HCT 66 biologic DMARD 66 bone marrow reticulin deposition 66 FOLFOX4 alone 66 PEGylated anti 66 arsenic trioxide injection 66 aspirin heparin 66 Doxil ® 66 pegylated interferon alpha 2a 66 peginterferon alfa 2a 66 #mg dosing group 66 mg/# hr 66 Relapsing Multiple Sclerosis 66 estramustine 66 comparator arm 66 Initiate Phase 66 Patients Treated With 66 BARACLUDE ® 66 antiretroviral naïve 66 topical gel formulation 66 oral prednisone 66 atazanavir ritonavir 66 #.#mg/dL 66 interferon ribavirin 66 Meets Primary Endpoint 66 Mycophenolate Mofetil 66 anthracycline taxane 66 atazanavir sulfate 66 Pegasys ® 66 FOLFOX6 66 PegIFN RBV 66 Paraplatin ® 66 cetuximab Erbitux R 66 amprenavir 66 Phase IIb Trial 66 somatostatin analog 66 PREZISTA r 66 vinorelbine tartrate 66 Peginterferon alfa 2b 66 biphasic insulin aspart 66 aminotransferase elevations greater 66 treatment naive genotype 66 EURIDIS 66 mg q8h 66 sunitinib Sutent ® 66 CCyR 66 lenalidomide Revlimid R 66 5 fluorouracil leucovorin 66 IFN alfa 66 bupropion SR 66 voriconazole 66 Single Dose 66 liposome injection 66 BENICAR 66 cisplatin gemcitabine 66 #mg dose [002] 66 chemoradiation therapy 66 doxazosin 66 cis retinoic acid 66 xanthine oxidase inhibitor 66 interferon beta 1a infertility 66 paclitaxel Taxol R 66 Capecitabine 66 azilsartan medoxomil 66 ABC/3TC 66 #mg/#mg 66 rizatriptan 66 pegylated interferon alfa 2b 66 adefovir dipivoxil 66 novel VDA molecule 66 dose cohort 66 subcutaneous SC 66 insulin detemir 65 antiretroviral naive 65 5mg/kg 65 trastuzumab Herceptin R 65 lanreotide 65 #mg ATC 65 adjunctive placebo 65 #mg/day [001] 65 Mg Usa 65 orally administered inhibitor 65 tazobactam 65 pharmacologically active isomer 65 liposomal formulation 65 TAXOTERE R 65 #mg/kg [002] 65 Severe Sepsis 65 nucleoside analog 65 telaprevir dosed 65 activated partial thromboplastin 65 daunorubicin 65 Adefovir 65 ancrod 65 daily Infergen 65 subcutaneously administered 65 PEG Intron 65 Pharmacokinetics PK 65 intradermal injections 65 bolus injection 65 Patients Treated 65 mg RDEA# 65 receiving highly emetogenic 65 brand ciclesonide HFA 65 REYATAZ r 65 biochemical relapse 65 HBeAg negative patients 65 nevirapine NVP 65 octreotide acetate 65 μg kg 65 goserelin 65 Aflibercept 65 gemcitabine carboplatin 65 hydroxymethyl coenzyme 65 cyclophosphamide doxorubicin vincristine 65 Phase 2b Clinical Trial 65 bortezomib refractory 65 vinca alkaloid 65 COPEGUS 65 Pemetrexed 65 Prograf ® 65 mg tid 65 naïve HCV 65 zoledronate 65 boosted protease inhibitor 65 Folfox 65 Bezielle 65 HBeAg + 65 APTIVUS r 65 Newly Diagnosed Multiple Myeloma 65 docetaxel Taxotere R 65 Alkeran 65 neurologic progression 65 Coadministration 65 ug dose 65 rifapentine 65 refractory NSCLC 65 PEGylated Fab fragment 65 Mg Uk 65 Myocardial Infarction Study 65 pegylated interferon peg IFN 65 Tarceva TM 65 mg eq 65 beta2 agonist 65 pyrexia mucositis sepsis febrile 65 Elitek 65 ritonavir boosted lopinavir 65 mild renal insufficiency 65 RLAI 65 FOLFOX4 65 irbesartan 65 alpha 2b 65 peginterferon alfa 2a #KD 65 inhalations twice 65 ara C 65 #.#mg/kg [002] 65 ORENCIA ® 65 sorafenib Nexavar 65 hours postdose 65 #mg doses [002] 65 DOXIL 65 COPEGUS R 65 nicardipine 65 administered intranasally 65 PEG interferon 65 tolterodine ER 65 plus OBT 65 mycophenolate mofetil 65 MAGE A3 ASCI 65 primary hypercholesterolemia 65 5mg #mg 65 postmenopausal osteoporotic women 65 Complicated Skin 65 Plus Ribavirin 65 ceftazidime 65 CCX# B 65 FIRMAGON 65 zolmitriptan 65 telaprevir dosing 65 unresectable HCC 65 refractory chronic lymphocytic 65 Study Evaluating 65 stage IIIB 65 IMiDs ® compound 65 pegylated liposomal doxorubicin 65 dacarbazine DTIC 65 Orally administered 65 bevacizumab Avastin R 65 ALN HPN 65 Pivotal Phase III 65 plus MTX 65 telaprevir pegylated interferon 65 vapreotide acetate 64 Betaferon R 64 virologic failure 64 PREZISTA r arm 64 adefovir 64 Telithromycin 64 mitoxantrone 64 #mg #mg [001] 64 ULORIC 64 achieved sustained virologic 64 pamidronate 64 teriflunomide 64 abacavir sulfate lamivudine 64 idarubicin 64 COMBIVIR 64 Engerix B 64 R Saizen R 64 metastatic GIST 64 Adjuvant Treatment 64 HBeAg seroconversion 64 FOLFOX6 chemotherapy regimen 64 fluvastatin 64 lintuzumab SGN 64 lenalidomide dexamethasone 64 daily subcutaneous injections 64 placebo dexamethasone 64 AGILECT R 64 melphalan prednisone 64 hour bronchodilation 64 Interferon beta 1b 64 epoetin beta 64 pegylated alpha interferon 64 detemir 64 antithymocyte globulin 64 MCyR 64 ADP receptor antagonist 64 carboplatin AUC 6 64 relapsed CLL 64 Neoadjuvant 64 efavirenz emtricitabine 64 GW# [003] 64 intravenous bolus injection 64 dose cytarabine 64 metformin sulfonylurea 64 mg dosed twice 64 beclomethasone dipropionate 64 plus GP IIb 64 peg IFN 64 ATACAND 64 chlorambucil 64 benzoic acid hyoscyamine sulfate 64 mg kg BID 64 HCV SPRINT 64 FOLFOX 64 CTAP# Capsules 64 subcutaneous doses 64 1mg 2mg 64 severe renal impairment 64 epirubicin cyclophosphamide 64 indinavir 64 intermittent dosing 64 inhalation powder 64 rabeprazole 64 ALT normalization 64 ertapenem 64 anthracyclines taxanes 64 NovoLog ® Mix 64 Viread Emtriva 64 dose dose escalation 64 Abrupt discontinuation 64 corticosteroid dose 64 CIMZIA TM certolizumab pegol 64 octreotide LAR 64 mg q#h 64 Darunavir 64 Natalizumab 64 Pegylated Interferon 64 mcg mL 64 Omacetaxine 64 LEXIVA 64 CLARITY study 64 VIRAMUNE 64 unresectable stage 64 Copegus 64 Pivotal Phase 64 response CCyR 64 oxaliplatin Eloxatin 64 terfenadine 64 PEGylated interferon beta 1a 64 sunitinib Sutent 64 forodesine 64 Castration Resistant Prostate Cancer 64 Adjunctive Therapy 64 mg p = 64 Platinol ® cisplatin 64 Zorbtive TM 64 long acting muscarinic 64 mg/# hours 64 Hsp# Inhibitor 64 VARIVAX 64 EUFLEXXA R 64 RAPTIVA 64 atorvastatin #mg 64 aspartate aminotransferase AST 64 valacyclovir 64 TDF FTC 64 Neulasta ® 64 trimethoprim sulfamethoxazole 64 balsalazide disodium Capsules 64 Peginterferon alfa 2a 64 aPTT 64 mg d 64 oral antidiabetic medication 64 intramuscularly 64 LENALIDOMIDE 64 interferon alfa 64 venlafaxine Effexor 64 Irinotecan 64 randomized #:#:# 64 headache nasopharyngitis 64 oral levofloxacin 64 Platinol ® 64 standard chemotherapy regimen 64 Azacitidine 64 serum phosphorous 64 IN PATIENTS WITH 64 ribavirin Copegus ® 64 Parathyroid Hormone 64 endoscopic remission 64 Amgen Neulasta ® 64 ALGRX 64 PEG Interferon alfa 64 inhibitor RG# 64 cisplatin vinorelbine 64 CHOP chemotherapy 64 mGluR5 negative 64 phenyl salicylate methylene blue 64 HGS ETR2 64 mitoxantrone chemotherapy 64 tenofovir disoproxil fumarate 64 GOUT 64 PRADAXA #mg 64 protease inhibitor PI 64 CANCIDAS 64 Raptiva r 64 demonstrated antitumor activity 64 Metastatic Prostate Cancer 64 ibandronate 63 dosage regimens 63 Free Survival PFS 63 Phase 2b Trial 63 imatinib Gleevec ® 63 fosamprenavir 63 immunomodulatory therapy 63 advanced hepatocellular carcinoma 63 LymphoStat B belimumab 63 transdermal fentanyl 63 myelodysplastic myeloproliferative diseases 63 benazepril 63 dopamine partial agonist 63 mCi 63 TLUS 63 tolterodine 63 Pegylated interferon 63 #/#.# mg 63 TTF Therapy 63 oral vancomycin 63 Sandostatin R 63 Nilotinib 63 -#.# log# 63 mg subcutaneously 63 fluticasone propionate 63 low dose cytarabine 63 Certolizumab 63 dapagliflozin plus 63 Chronic Hepatitis C 63 darunavir r 63 Monotherapy 63 Indacaterol 63 fluoropyrimidine 63 pooled comparator 63 Phase IIb Clinical Trial 63 vinorelbine 63 irinotecan containing 63 hyperphenylalaninemia HPA due 63 mcg Albuferon 63 nucleoside reverse transcriptase inhibitor 63 LEVAQUIN ® 63 null responder HCV 63 Is Well Tolerated 63 colesevelam HCl 63 zidovudine lamivudine 63 Known hypersensitivity 63 gemcitabine Gemzar 63 inhaled corticosteroid ICS 63 Panzem R NCD 63 ascending dose 63 receiving XGEVA 63 Copegus ® 63 interferon gamma 1b 63 Previously Treated 63 receiving VICTRELIS 63 oral renin inhibitor 63 erlotinib Tarceva ® 63 Omacetaxine mepesuccinate 63 Budesonide 63 plus ribavirin 63 pegIFN 63 mg kg IV 63 Navelbine ® 63 cyclophosphamide vincristine 63 de novo kidney transplant 63 receiving PEGINTRON 63 docetaxel Taxotere 63 antibody MAb 63 docetaxel Injection Concentrate 63 Camptosar ® 63 Adalimumab 63 amoxicillin clavulanate 63 abacavir Ziagen 63 subcutaneous dose 63 histologically confirmed 63 Pharmacokinetic parameters 63 SVR# 63 receiving prophylactic anticoagulation 63 APTIVUS R 63 corifollitropin alfa 63 Double Blind Randomized 63 insulin glargine rDNA origin 63 Forodesine HCl 63 cEVR 63 sufentanil 63 TMP SMX 63 bendamustine ifosfamide 63 subcutaneous injections 63 Acute Ischemic Stroke 63 ethambutol 63 leukemia AML 63 REMICADE monotherapy 63 Mitoxantrone 63 Relapsed Multiple Myeloma 63 Naive Patients 63 2 methoxyestradiol 63 darunavir ritonavir 63 generation purine nucleoside 63 receptor tyrosine kinase inhibitor 63 tirofiban 63 paclitaxel poliglumex 63 #μg [002] 63 REYATAZ R 63 moderate hepatic impairment 63 bolus dose 63 Cyclophosphamide 63 prucalopride 63 Decitabine 63 mg m 63 EGFR TKI 63 insulin aspart 63 antiandrogen 63 active comparator 63 metformin HCl 63 aripiprazole Abilify 63 Fluticasone 63 Ondansetron Injection USP 63 tenofovir FTC 63 thiazide diuretic 63 AVONEX ® 63 elevated transaminases 63 bisoprolol 63 mg kg hr 63 dihydrochloride 63 maximally tolerated dose 63 Patients Receiving 63 otamixaban 63 Intravitreal 63 EXPAREL TM 63 alkylating agent 63 cidofovir 63 undetectable HBV DNA 63 divalproex sodium 63 remifentanil 63 hypophosphatemia 63 mapatumumab 63 Trial Evaluating 63 dose regimens 63 Telbivudine 63 intravenous REOLYSIN 63 ABRAXANE therapy 63 recurrent genital herpes 63 6mg 63 refractory AML 63 5 Fluorouracil 63 intravenous IV infusion 63 Randomized Double Blind 63 hypertrichosis occurred 63 Xelox 63 Stent Restenosis 63 Tezampanel 63 Teriflunomide 63 Xibrom TM 63 Phase III Clinical Trial 63 Relapsed Refractory 63 Diovan Exforge Tekturna Zelnorm 63 oral ridaforolimus 63 nilotinib Tasigna ® 63 intravenously administered 63 QTcF 63 epoetin alpha 63 log# IU mL 63 #mg dose [001] 63 ß blockers 63 Traficet EN 63 mometasone furoate 63 kBq kg 63 FDA APPROVES 63 INVANZ 63 Median PFS 63 log# copies mL 63 intranasal formulation 63 QD dosing 63 metastatic malignant 63 peripherally acting 63 Taxotere R 63 Abciximab 63 paclitaxel carboplatin 63 medroxyprogesterone acetate 63 REVIVE Diabetes 63 rapid virologic response 63 Sandostatin 63 lamivudine 3TC 63 Ranolazine 63 Dasatinib 63 Antitumor Activity 63 ALVESCO 63 dose cohorts 63 cefazolin 63 -#.# log# copies mL 63 doxorubicin docetaxel 63 peginterferon alfa 63 8mg 63 TNF Tumor Necrosis Factor 63 metastatic hormone refractory 62 debulking surgery 62 blinded randomized placebo controlled 62 Phase 2b Study 62 plus medroxyprogesterone acetate 62 decitabine 62 prednisone prednisolone plus 62 FOLPI 62 leuprorelin 62 NPH insulin 62 virus HCV protease inhibitor 62 oral allopurinol 62 timepoints 62 Prognostic significance 62 Serevent salmeterol 62 HGS# 62 undetectable virus HCV 62 adalimumab 62 ARB telmisartan 62 epirubicin 62 Interferon Beta 62 cinacalcet 62 mycophenolate mofetil MMF 62 evaluable subjects 62 oxybutynin 62 sitaxsentan 62 cyclophosphamide chemotherapy 62 mg subcutaneous injection 62 aspirin clopidogrel 62 Placebo Controlled Study 62 docetaxel prednisone 62 Moxifloxacin 62 HBeAg positive 62 mg dose 62 Fludara ® 62 mesalamine granules 62 Initiated Phase 62 Dose Ranging Study 62 imipenem 62 carbamazepine phenobarbital phenytoin rifampin 62 AZT 3TC 62 beclomethasone 62 ritonavir boosted protease inhibitor 62 selective modulator 62 nausea dehydration dyspnea 62 #mg dosing 62 Solid Tumors criteria 62 SCIg 62 rimonabant #mg/day 62 nucleotide analogue 62 SGPT 62 GnRH agonist 62 epirubicin cisplatin 62 administered concomitantly 62 diuretic chlorthalidone 62 R emtricitabine 62 Cutaneous T 62 Medoxomil 62 Prolongs Survival 62 oral prodrug 62 fluticasone 62 fallopian tube cancers 62 Vincristine 62 Alpha interferons including 62 Fludara 62 Fluorouracil 62 Ovitrelle R Serostim 62 R ribavirin USP 62 aspartate aminotransferase 62 splenectomized 62 tacrolimus ointment 62 NRTI 62 prednisone CHOP 62 phase III isavuconazole 62 Contrave# 62 evaluating Xcytrin 62 Pegasys plus Copegus 62 II Clinical Trial 62 Pooled Analysis 62 plus 5-FU/LV 62 NRTI backbone 62 methotrexate monotherapy 62 INSPIRE Trial Phase III 62 stavudine d4T 62 metastatic CRC 62 Kinoid 62 Tanespimycin 62 plus glycoprotein IIb 62 undetectable HCV RNA 62 paclitaxel Taxol ® 62 HMG CoA reductase inhibitors 62 #mg doses [001] 62 platelet inhibitor 62 PROCTOCORT ® Suppository Hydrocortisone 62 EPIVIR 62 CYT# potent vascular disrupting 62 Neulasta R 62 CLINICAL STUDIES 62 ketorolac 62 remission induction 62 oral hypoglycemic agent 62 Cmax 62 neoadjuvant 62 mycophenolic acid 62 moderate renal impairment 62 receiving golimumab 62 pomalidomide 62 5 fluorouracil 62 alefacept 62 See CLINICAL PHARMACOLOGY 62 non nucleoside inhibitor 62 Daptomycin 62 folinic acid 62 Gemcitabine 62 ZOLINZA 62 Enoxaparin 62 mg/# h 62 IN COMBINATION WITH 62 AMEVIVE 62 Inhalation Aerosol 62 NSABP B 62 achieved PASI 62 Angiotensin Converting Enzyme 62 pioglitazone HCl 62 Placebo Controlled Trial 62 ALT elevations 62 ABVD 62 nitrofurantoin 62 Epoetin Alfa 62 mcg kg REBETOL 62 reduce serum phosphate 62 Randomized Double Blind Placebo 62 tinzaparin 62 MIRAPEX 62 ACE inhibitor ramipril 62 aplastic anemia AA 62 HCV genotype 62 pegfilgrastim 62 Amgen Neulasta R 62 nucleoside naive 62 fluorouracil 62 paroxetine Paxil 62 genotypic resistance 62 Completes Patient Enrollment 62 Demonstrated Significant 62 J Am Coll 62 acyclovir Lauriad R 62 novel emulsion formulation 62 mesalazine 62 underwent surgical resection 62 Saquinavir 62 tenofovir Viread 62 titrated glipizide 62 MMX mesalamine 62 Relapsed 62 sapropterin dihydrochloride 62 microg 62 alfuzosin 62 Oral Suspension Oral Suspension 62 dosing intervals 62 methylergonovine 62 patients coinfected 62 indinavir Crixivan 62 Refractory Hodgkin Lymphoma 62 DOXIL ® 62 dose dexamethasone 62 Cilostazol 62 Atripla combines 62 Hydrochlorothiazide 62 tobramycin inhalation solution 62 Antiviral Activity 62 Myelodysplastic Syndrome MDS 62 Demonstrates Potent 62 FOLPI regimen 62 Inhalation Solution 62 nonnucleoside reverse transcriptase inhibitor 62 mRCC 62 receptor blocker 62 p = NS 62 IELT 62 enalapril 62 dihydroergotamine DHE 62 haloperidol Haldol 62 β blockers 62 cyclophosphamide doxorubicin 62 IXEMPRA 62 #.#mg 1mg 62 5FU 62 oral diclofenac 62 opioid naive 62 generalized edema 62 rFVIIa 62 Quinamed 62 partial remissions 62 CIMZIA ™ 62 azathioprine 62 cell lymphoma CTCL 62 ENDOMETRIN R 62 stage IIIb 62 intra articular injection 62 Taxotere ® 62 Hylan GF 62 baminercept 62 nelfinavir 62 Sitagliptin 62 visilizumab 62 doripenem 62 radiotherapy RT 62 postdose 62 #Gy 62 virologically suppressed 62 taxotere 62 carboplatin chemotherapy 62 transcriptase inhibitor NNRTI 62 INTEGRILIN R 62 Lubiprostone 62 #/#.# mcg 62 pyrimidine nucleoside analog 62 dose escalation phase 62 cells uL 62 Adjunctive 62 Controlled Trial 62 MIRAPEX ER 62 glatiramer acetate 62 Emtriva Viread 62 VNP#M 62 lamivudine zidovudine 62 tapentadol ER 62 ritonavir Norvir 62 beta 1a 62 R bisoprolol Euthyrox 62 intravenous dosing 61 Ziprasidone 61 Kivexa 61 BYSTOLIC 61 ropinirole 61 oxycodone IR 61 Vinorelbine 61 Blinatumomab 61 formoterol fumarate 61 lumbar spine bone 61 PROCTOCORT R Cream Hydrocortisone 61 malignancy HCM 61 azacitidine 61 CLL SLL 61 mCi m 2 61 Neupogen ® 61 Treatment Naive Patients 61 mcg linaclotide 61 #mg #mg [002] 61 events SAEs 61 refractory CTCL 61 TELINTRA 61 REVLIMID ® 61 infusional 5-FU/LV 61 ropivacaine 61 #mg BID [002] 61 kilogram mg kg 61 Treated Patients 61 Blind Placebo Controlled Trial 61 taxane resistant 61 dosed orally 61 morphometric vertebral fractures 61 Well Tolerated 61 bendamustine 61 R metformin Concor 61 ELACYT 61 lexidronam injection 61 Apidra ® 61 steroid refractory ulcerative 61 lumbar spine BMD 61 intravenous iv